Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: manny_velasco who wrote (22330)	12/24/2005 1:57:08 PM
From: E_K_S	Read Replies (1) of 78594

Hi manny velasco - It appears that the FDA Approved Bristol-Myers Squibb's New Rheumatoid Arthritis Drug Friday after the market close. The stock is trading up 5% back to $24.00. biz.yahoo.com It's not too often we see multi year lows for any of the major drug company and selling at PE's in their teens. Many still have problems to work through but others like BMY may be on track w/ getting their new drug pipeline in place. I have a big "Value" bet on many of these drug companies (for the long term) and I am glad to see that at least one of them is beginning to pay off. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next